Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

Date 21/07/2021 Patient ID 33216408

Name MR. Abhishek Mudgal SP Coll. 21/07/2021 15:03:31


Sex / Age Male/22 Yrs SP Rec. 21/07/2021 15:03:32
Ref byDr. CDMO NORTH DELHI -NARELA Auth Dt 21/07/2021 21:10:29
SRF ID 0708000888328 Print Dt. 21/07/2021 23:20:54
Sample Nasopharyngeal & Oropharyngeal Mobile No - 9899949858

Molecular Biology
RTPCR TEST FOR COVID 19 SAMPLE COLLECTED
AT CENTRE
E Gene / N Gene Negative
ORF1a/ORF1b/N/N2 Gene Negative
Final Result Negative
INTERPRETATION
RESULT COMMENT
E gene Negative Absence of B Beta CoV RNA indicate no infection with lineage B-betacoronavirus
Both E gene AND Orf1A/RDRP gene Negative Absence of B-Beta CoV RNA and SARS-CoV RNA indicate no infection with lineage B-
betacoronavirus
E gene Positive AND Orf1A/RDRP gene Presence of B Beta-CoV RNA indicates infection with lineage betacoronavirus virus
Negative BUT absence of COVID-19
Both E gene AND Orf1A/RDRP gene Positive Presence of B Beta-CoV RNA and SARS-CoV RNA indicate infection with COVID-19
E gene Negative but Orf1A/RDRP gene Positive Inconclusive, As per guidelines a repeat sample is recommended.
A Single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection. False Negative results may be
seen in samples collected too early or late in the clinical course of the infection. Close monitoring of symptoms and retesting may be considered, as per
clinical evaluation. The repeat specimen may be considered after a gap of 2-4 days after the collection of the first specimen for additional testing, if
required.
TEST ATTRIBUTES AND LIMITATION
1. Samples must be received at the laboratory under appropriate conditions within 48 hours of collection to ensure preservation of viral RNA.
2. Negative result does not rule out the possibility of COVID-19 infection. Presence of inhibitors, mutations and insufficient organisms RNA can influence
the result. False Negative result may be seen in samples collected too early ore too late in the clinical course of the infection. Kindly refer to the
latest ICMR guidelines.
3. A single negative test result, particularly if this is from an upper respiratory tract specimen does not exclude infection. A positive alternate pathogen
does not necessarily rule out COVID-19 infection, as little is yet known about the role of co-infections.
4. Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimen may be
considered after a gap of 2-4 days after the collection of the first specimen for additional testing if required.
Test is done on: Real Time Polymerase Chain Reaction (RT-PCR).
ICMR Registration No GDICPLD.

*** End of Report ***

DR ARCHANA PRAKASH DR SHAHEEN BHAT DR Mandeep Kaur DR JOGINDER SINGH


PhD. MICROBIOLOGY MBBS,MD MBBS,MD,MICROBIOLOGIST PhD. BIOTECHNOLOGY
Consultant Microbiologist
www.busysoft.in

Checked By.: DRARCHNA


Page No: 1 of 1

You might also like